Lumanity Ltd. - MassBio

Overview

Lumanity applies incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimize access to medical advances. With deep experience in medical, commercial, and regulatory affairs, Lumanity transforms data and information into real-world insights and evidence that powers successful commercialization and empowers patients, providers, payers, and regulators to take timely and decisive action.

Lumanity serves its clients across three complementary areas:

Asset Optimization and Commercialization: highly experienced real-world commercial, scientific, clinical, partnering and dealmaking experts guiding confident and robust commercial decision making across the lifecycle from concept through development, launch, and commercialization
Value, Access and Outcomes: industry leading health economists, data analysts, statisticians, and market access experts supporting health technology assessment (HTA) strategy and submissions, driving a real-world understanding of burden of illness and the patient journey, uncovering the full market potential of products, and demonstrating their value to stakeholders around the world
Medical Strategy and Communications: experts in scientific strategy, planning, execution and communications working to effectively articulate scientific breakthroughs to enable regulators, payers, and patients to understand and appreciate a product’s holistic value

With offices in the North America, the United Kingdom, European Union, and Asia, and work conducted in over 50 countries, its 1,200+ experts work with nearly all the top pharmaceutical companies and more than 100 biotech companies around the world. Turning aspiration into reality, Lumanity support over 50 payer submissions across 20+ countries, launch readiness and commercialization of 80 brands and new indications, and numerous award-winning product campaigns every year.